ArticleFrontiers in pharmacology2026

Brusatol suppresses meningioma progression via targeting HMGCR to restrict the cholesterol biosynthesis and inhibit PI3K/AKT signaling pathway.

Huaning Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.